Linzess (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Linzess drug offered from Avera McKennan Hospital. This Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | linaclotide |
| SUBSTANCE NAME: | LINACLOTIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-06-04 |
| END MARKETING DATE: | 0000-00-00 |
Linzess HUMAN PRESCRIPTION DRUG Details:
| Item Description | Linzess from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 145(ug/1) |
| START MARKETING DATE: | 2015-06-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-1202_1edb6e03-3ec3-41b3-866c-ef5f41311c13 |
| PRODUCT NDC: | 69189-1202 |
| APPLICATION NUMBER: | NDA202811 |
Other LINACLOTIDE Pharmaceutical Manufacturers / Labelers:
